Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duvaraka Kula-Alwar

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Circulation|December 10, 2019
Targeting Succinate Metabolism in Ischemia/Reperfusion InjuryDuvaraka Kula-Alwar, Hiran A Prag, Thomas Krieg
Developmental Biology|November 27, 2020
Mef2c factors are required for early but not late addition of cardiomyocytes to the ventricleDuvaraka Kula-Alwar, Michael S Marber, Simon M Hughes, et al.
Journal of Molecular and Cellular Cardiology|October 9, 2022
Cyclophilin D knockout mice do not accumulate succinate during cardiac ischemiaHiran A Prag, Duvaraka Kula-Alwar, Paolo Bernardi, et al.
Molecular Pharmaceutics|July 22, 2020
Selective Delivery of Dicarboxylates to Mitochondria by Conjugation to a Lipophilic Cation via a Cleavable LinkerHiran A Prag, Duvaraka Kula-Alwar, Laura Pala, et al.
Nature Communications|January 30, 2021
Structural basis for a complex I mutation that blocks pathological ROS productionZhan Yin, Nils Burger, Duvaraka Kula-Alwar, et al.
Circulation Research|August 12, 2022
Ischemia-Selective Cardioprotection by Malonate for Ischemia/Reperfusion InjuryHiran A Prag, Dunja Aksentijevic, Andreas Dannhorn, et al.
Journal of Cellular and Molecular Medicine|May 9, 2020
Cardiac metabolism as a driver and therapeutic target of myocardial infarctionCoert J Zuurbier, Luc Bertrand, Christoph R Beauloye, et al.
Cardiovascular Drugs and Therapy|July 11, 2020
Ester Prodrugs of Malonate with Enhanced Intracellular Delivery Protect Against Cardiac Ischemia-Reperfusion Injury In VivoHiran A Prag, Laura Pala, Duvaraka Kula-Alwar, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Circulation|December 10, 2019
Targeting Succinate Metabolism in Ischemia/Reperfusion InjuryDuvaraka Kula-Alwar, Hiran A Prag, Thomas Krieg
Developmental Biology|November 27, 2020
Mef2c factors are required for early but not late addition of cardiomyocytes to the ventricleDuvaraka Kula-Alwar, Michael S Marber, Simon M Hughes, et al.
Journal of Molecular and Cellular Cardiology|October 9, 2022
Cyclophilin D knockout mice do not accumulate succinate during cardiac ischemiaHiran A Prag, Duvaraka Kula-Alwar, Paolo Bernardi, et al.
Molecular Pharmaceutics|July 22, 2020
Selective Delivery of Dicarboxylates to Mitochondria by Conjugation to a Lipophilic Cation via a Cleavable LinkerHiran A Prag, Duvaraka Kula-Alwar, Laura Pala, et al.
Nature Communications|January 30, 2021
Structural basis for a complex I mutation that blocks pathological ROS productionZhan Yin, Nils Burger, Duvaraka Kula-Alwar, et al.
Circulation Research|August 12, 2022
Ischemia-Selective Cardioprotection by Malonate for Ischemia/Reperfusion InjuryHiran A Prag, Dunja Aksentijevic, Andreas Dannhorn, et al.
Journal of Cellular and Molecular Medicine|May 9, 2020
Cardiac metabolism as a driver and therapeutic target of myocardial infarctionCoert J Zuurbier, Luc Bertrand, Christoph R Beauloye, et al.
Cardiovascular Drugs and Therapy|July 11, 2020
Ester Prodrugs of Malonate with Enhanced Intracellular Delivery Protect Against Cardiac Ischemia-Reperfusion Injury In VivoHiran A Prag, Laura Pala, Duvaraka Kula-Alwar, et al.
Pageof 1